# Iron Supplement in the Prevention of Anemia in Female Breast Cancer Patients

> **NCT01168505** · PHASE2 · UNKNOWN · sponsor: **Instituto do Cancer do Estado de São Paulo** · enrollment: 100 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** ferric hydroxide saccharate

## Key facts

- **NCT ID:** NCT01168505
- **Lead sponsor:** Instituto do Cancer do Estado de São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-05
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01168505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01168505, "Iron Supplement in the Prevention of Anemia in Female Breast Cancer Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01168505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*